Biren Amin

Stock Analyst at Piper Sandler

(0)
# 4619
Out of 5,243 analysts
78
Total ratings
30.95%
Success rate
-17.46%
Average return
47 Stocks
Name Action Price Target Current % Upside Ratings Updated
Viking Therapeutics
Initiates Coverage On: Overweight
74
34 117.65% 1 Dec 2, 2024
Corbus Pharmaceutica...
Initiates Coverage On: Overweight
35
12.11 189.02% 1 Dec 2, 2024
Sarepta Therapeutics
Maintains: Overweight
200 182
118.94 53.02% 5 Nov 27, 2024
Immunome
Maintains: Overweight
23 21
9.59 118.98% 3 Nov 14, 2024
Allogene Therapeutic...
Maintains: Overweight
11 9
1.85 386.49% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
91 115
64.78 77.52% 2 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
40 32
29.17 9.7% 2 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
46
34.57 33.06% 1 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 34
11.85 186.92% 2 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 3
3.17 -5.36% 1 Jul 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
20 20
3.22 521.12% 1 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 15
8.15 84.05% 1 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
10
0.72 1288.89% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 70
2.77 2427.08% 2 May 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
59 34
n/a n/a 2 Feb 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
51
0.49 10308.16% 1 Jan 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
17
n/a n/a 2 Nov 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
4.88 391.8% 1 Oct 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
1.66 1948.19% 1 Oct 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
1050 500
7 7042.86% 2 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
5.75 143.48% 1 Jul 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
54
n/a n/a 1 Jul 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
657 691
705.59 -2.07% 2 Jun 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16 10
0.83 1104.82% 1 Jun 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Mar 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 68
n/a n/a 1 Dec 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Hold
11
n/a n/a 4 Sep 16, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10800 2400
n/a n/a 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
61 50
n/a n/a 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 4 Dec 11, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
101
15.13 567.55% 1 Nov 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
66 69
141.12 -51.11% 1 Oct 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
155
421.26 -63.21% 5 Jul 11, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Apr 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 3
n/a n/a 1 Mar 7, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
136
2.14 6255.14% 3 Mar 6, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jan 24, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 46
n/a n/a 1 Feb 3, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
70 60
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 18
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
29 28
n/a n/a 1 Jan 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
68 65
n/a n/a 1 Jan 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 65
n/a n/a 1 Jan 21, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
13 15
n/a n/a 1 Jan 20, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 15
n/a n/a 1 Jan 19, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 2
n/a n/a 1 Jan 19, 2016